Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACETYLLEUCINE, L- for Vestibular neuronitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where ACETYLLEUCINE, L- was used for Vestibular neuronitis.

Most Reported Side Effects for ACETYLLEUCINE, L-

Side Effect Reports % Deaths Hosp.
Off label use 43 28.9% 0 1
Renal failure 13 8.7% 0 4
Autoimmune haemolytic anaemia 10 6.7% 0 10
Death 10 6.7% 10 0
Hypoglycaemia 9 6.0% 0 0
Interstitial lung disease 9 6.0% 0 0
Ischaemic stroke 9 6.0% 0 9
Lactic acidosis 9 6.0% 0 0
Oxygen saturation decreased 9 6.0% 0 8
Pulmonary embolism 9 6.0% 0 1
Miosis 8 5.4% 0 8
Toxicity to various agents 8 5.4% 0 8
Acute generalised exanthematous pustulosis 7 4.7% 0 0
Pneumonia 7 4.7% 1 5

Other Indications for ACETYLLEUCINE, L-

Product used for unknown indication (56) Vertigo (30) Gm2 gangliosidosis (14) Ataxia (6) Neuronal ceroid lipofuscinosis (6) Niemann-pick disease (6)

Other Drugs Used for Vestibular neuronitis

ACYCLOVIR (9) VALACYCLOVIR (9) PREDNISONE (8)

Related Pages

ACETYLLEUCINE, L- Full Profile All Vestibular neuronitis Drugs ACETYLLEUCINE, L- Demographics ACETYLLEUCINE, L- Timeline